Crescentis Capital Limited Receives BSE In-Principle Approval for 13,00,000 ESOP Shares
Crescentis Capital Limited has obtained BSE in-principle approval for issuing 13,00,000 equity shares under its Employee Stock Option Scheme 2025. The approval, dated April 02, 2026, covers shares with ₹10 face value each and comes with specific compliance conditions including regulatory notifications, fee payments, and statutory approvals that must be fulfilled before share allotment to employees.

*this image is generated using AI for illustrative purposes only.
Crescentis capital Limited has received in-principle approval from BSE Limited for issuing equity shares under its employee stock option scheme. The approval covers 13,00,000 equity shares with a face value of ₹10 each, to be issued under the "Crescentis Capital Limited Employees' Stock Option Scheme 2025".
BSE Approval Details
The BSE granted approval through letter reference DCS/ESOP/IP/RD/006/2026-27 dated April 02, 2026. The company informed BSE about receiving this approval on April 04, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Parameter | Details |
|---|---|
| Approved Shares | 13,00,000 equity shares |
| Face Value | ₹10 per share |
| Scheme Name | Crescentis Capital Limited Employees' Stock Option Scheme 2025 |
| BSE Reference | DCS/ESOP/IP/RD/006/2026-27 |
| Approval Date | April 02, 2026 |
Compliance Conditions
BSE has set several conditions that Crescentis Capital Limited must fulfill before the shares can be allotted:
- Regulatory Notifications: The company must notify BSE as per Regulation 10(c) format after share allotment and crediting to beneficiaries' accounts
- Fee Payments: Payment of prescribed fees from time to time
- Statutory Approvals: Receipt of approvals from SEBI, RBI, MCA and other statutory authorities
- Documentation: Submission of required documents as per BSE checklist
- Legal Compliance: Adherence to Companies Act provisions and other applicable laws
Share Allotment Framework
The approved equity shares will be allotted to employees upon exercise of stock options under the Securities Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. BSE will issue trading permission from time to time upon receipt of proper notifications and compliance with stated conditions.
Company Background
Crescentis Capital Limited, formerly known as Som Datt Finance Corporation Limited, operates with CIN L65921TS1993PLC188494. The company is headquartered at JIVI Towers, Banjara Hills, Hyderabad, Telangana. V. V. Krishna Chaitanya serves as the Company Secretary and Compliance Officer.
BSE reserves the right to withdraw its in-principle approval if submitted information is found incomplete, incorrect, or misleading, or for any contravention of exchange rules and regulations.
Historical Stock Returns for Crescentis Capital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
What is the expected timeline for Crescentis Capital to fulfill all BSE compliance conditions and begin actual share allotments to employees?
How might this ESOP scheme impact Crescentis Capital's employee retention and recruitment strategy in the competitive financial services sector?
What percentage of the company's total equity will these 13 lakh shares represent, and how could this dilution affect existing shareholders?































